2016 annual financial data
Amphastar Pharmaceuticals 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was 15.11%.
Operating income was 15,692,000 USD and net income was 10,532,000 USD.
Operating cash flow was 38,560,000 USD.
Get free Amphastar Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 255,165,000 USD
- Operating income
- 15,692,000 USD
- Net income
- 10,532,000 USD
- Operating cash flow
- 38,560,000 USD